CITrials COVID-19 Update

We at CiTrials are continually up to date with our local, state, and federal health guidelines so that our daily activities including but not limited to volunteer visits, on-site services, study medications, supplies, and labs are not impacted.
As more of our counties open, more clinical studies are also open for participation. Our volunteers’ safety is our number priority as they enroll into studies. Our health care staff continue to follow strict safety requirements including checking body temperature, wearing of masks and social distancing for all our volunteers at our clinics in Bellflower, Santa Ana and Riverside. 
We want to thank our volunteers for dedicating their time to help the medical community advance medical research for the benefit of our fellow citizens. And a huge thank you to all the health care workers for keeping everyone safe. Mask On. Live On

CITrials is excited to announce merger with CenExel

CITrials is excited to announce merger with CenExel

CITrials COVID-19 Update

CITrials has contingency measures implemented to manage conducting clinical trials during COVID-19 – our teams + rate is currently 0%.

We will be open from 8:30 am to 7:00 pm, Monday through Sunday so that our volunteers can come into office with less stress and less total people!

CITrials is excited to announce merger with CenExel

CITrials is excited to announce merger with CenExel

CITrials is excited to announce that we are now part of CenExel Clinical Research, Inc., (“CenExel”).

This merger with CenExel allows CITrials to strengthen and increase the clinical studies that we offer in psychiatric and neurological research and new studies. To our patients, nothing changes except soon, there will be more clinical studies to participate in. Including studies in Pain, Vaccines, Ethnic-bridging, and Sleep.

“Our mission and performance are ideal complements to the CenExel’s operating culture, and we see this as an important means of serving our clients with more single- and multi-site studies.” said Debra Hoffmeyer, founder and CEO of CITrials.

To read the full press release please click here:  https://www.prnewswire.com/news-releases/cenexel-clinical-research-acquires-citrials-301243242.html